Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · TRUALT BIOENERGY LIMITED · 28 October 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
TRUALT BIOENERGY LIMITED
NSE: TRUALT · BSE: 544545
Fast Moving Consumer Goods › Fast Moving Consumer Goods › Agricultural Food & other Products › Other Agricultural Products

TRUALT BIOENERGY LIMITED

StateQ1 FY27 filed
Last close · 27 Oct 2026₹385.00
Market cap₹3.3k cr
TTM P/E · P/B · EV/EBITDA23.5 · 2.09 · 10.6

Produces ethanol from grain and sugar feedstock across five plants with a combined capacity of 2,000 KLPD, of which 1,300 KLPD is dual-feed. In Q1 FY27 the company produced and sold ~8.5 crore litres of ethanol at ~Rs 640 crore revenue, supplied mainly to oil marketing companies (OMCs) under India's ethanol blending programme. Compressed biogas (CBG) is being built out via two joint ventures — three plants (~60 TPD) with Sumitomo and six plants (72 TPD) with GAIL — scaling capacity from 10 TPD to a targeted 162 TPD by FY27 end. A sustainable aviation fuel (SAF) project of 100 million litre capacity is in development using Honeywell UOP technology, backed by a Rs 150 crore grant under PM JI-VAN Yojana. Fuel retail had 7 outlets operational at the time of the Q1 FY27 call with a target of ~100 outlets. Materials — feedstock such as grain and sugar — account for 61.2% of revenue, the dominant cost line, while capex runs at 29.6% of revenue as new plants come up. AR · MarketPing reader · 2026-08-02

Revenue streams, as the annual report describes them. Ethanol, Compressed Biogas (CBG), Sustainable Aviation Fuel (SAF), Fuel retail. Asset-heavy, capex-intensive biofuels platform with high reliance on government policy for ethanol allocation and blending targets

What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.

Exhibit 1: Financial summary, FY26–FY26 (all audited; no estimate years)

₹ crore · consolidatedFY26
Revenue1,728
EBITDA (ex other income)290
margin %16.8
Owners' profit96
EPS, as reported (₹)12.30
ROE % · ROCE %6.1 · 10.8
Debt / equity (x)1.04
Cash from operations(289)
Capex(511)
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · TRUALT BIOENERGY LIMITED · 28 October 2026Page 2 of 3

Exhibit 2: Quarterly performance, last 5 quarters

₹ croreQ1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue304115713596627
Profit before tax6(49)908478
Net profit5(38)696159
EPS (₹)0.67(5.37)8.076.996.67
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.

Exhibit 3: Peers — basic industry group, by market cap

CompanyM.cap ₹ crP/EP/BEV/EBITDAROE %ROCE %Rev CAGR 5y %EBITDA m. %
LT FOODS LIMITED13,57921.23.0011.613.816.018.711.5
KRBL LIMITED8,10810.71.408.411.214.78.824.9
GUJARAT AMBUJA EXPORTS LT6,62815.92.0112.49.211.74.017.0
KAVERI SEED CO. LTD.3,50314.22.009.416.917.06.140.1
TRUALT BIOENERGY LIMITED ◆3,30123.52.0912.96.14.8—23.5
INDRAYANI BIOTECH LTD.2,98422.429.23218.81.90.245.68.2
AMIR CHAND JAG KUM (E) L2,24921.52.4313.111.214.8—9.5
GRM OVERSEAS LIMITED1,82313.93.0117.112.316.517.28.4
Source: exchange data and filed statements via the screener; multiples at current prices.

Exhibit 4: Where the company sits in its group

MetricCompanyGroup medianRankBetter than
P/E (TTM)23.512.344 of 5317%
P/B2.11.632 of 5136%
ROCE4.84.132 of 6753%
ROE6.13.522 of 5158%
Debt / Equity1.00.441 of 5120%
EBITDA margin23.59.78 of 4584%
Revenue growth106.310.33 of 5196%
Profit growth1154.416.63 of 5196%
Market cap3301665 of 6994%
Source: MarketPing peer ranks; a rank is a measurement, not a view.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · TRUALT BIOENERGY LIMITED · 28 October 2026Page 3 of 3

Exhibit 5: Filings of the last 90 days, with the measured price reaction

Date · filingCategoryImportanceNext day %5-day %
26 Oct 2026 · Earnings call recording for quarter and half year ended September 30, 2026investor communicationslow——
24 Oct 2026 · September 2026 quarter and half-year results approvedresultshigh——
24 Oct 2026 · Unaudited results for September 2026 quarter and half year publishedcomplianceminimal——
23 Oct 2026 · Investor presentation submitted to NSEinvestor communicationsmedium——
23 Oct 2026 · Strong H1 FY27 growth as revenue jumps 243 percent and profit turns positivecompliancelow——
23 Oct 2026 · Q2 and H1 FY27 results approved with unmodified reviewresultshigh——
17 Oct 2026 · Resignation of Company Secretary Mr Monu Kumarmanagement changeshigh——
16 Oct 2026 · Q2 FY27 earnings call scheduled for October 26 at 11:30 AMboard shareholder meetingslow——
14 Oct 2026 · Board meeting on Oct 23 to consider Q2 FY27 resultsresultslow——
13 Oct 2026 · Postal Ballot Notice Published in Newspaperscomplianceminimal——
Source: exchange announcements; each reaction is measured from the close before the filing. Next day = the close one session after the reaction day (the first session that could trade the filing).

How to read this document

Where a broker report showsThis document showsWhy
A rating (BUY / ADD / REDUCE / SELL)A state: the latest filed quarter and the measured reactionsan event is a fact; a rating is an opinion that requires SEBI RA registration
A target price and upsideThe current price and the multiples against the groupa target is a forecast; a multiple is a measurement
Estimate years marked EMore audited years; no estimatesMarketPing publishes no forecasts — your own model lives on the Models page

Sources, method and disclosures

This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.

Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in